Captura de pantalla 2026-06-19 a la(s) 11.45.06 a.m..png

Complete metabolic diagnosis in less than 30 minutes — right in your office.

MetriSense is the first rapid point-of-care test that simultaneously measures leptin, adiponectin, and insulin in a single sample. No lab. No waiting. Actionable results in the same appointment.

Request a demo

Technology developed in:

Metabolic diagnosis comes late

Detecting insulin resistance, metabolic syndrome, or subclinical inflammation currently requires a centralized laboratory, patient transport, and up to three weeks of waiting time. There is no commercially available rapid test that measures leptin or adiponectin in a portable format.

37%

of people with undiagnosed diabetes in Mexico

40%

of adults with metabolic syndrome

3 weeks

average lab result time

$4,675

MXN maximum cost per ELISA test

MetriSense brings advanced metabolic diagnostics directly to the doctor's office.

What does it measure?

How does it work?

Leptin: a marker of inflammation and satiety

Adiponectin: regulator of insulin sensitivity

Insulin: a direct indicator of metabolic resistance

LFA platform with fluorescent detection by europium particles (Eu³⁺). High-affinity antibodies capture all three biomarkers simultaneously. Results in less than 30 minutes.

10–20 minute training. No spin cycle. No special refrigeration required. Operable by non-specialized personnel.

No other portable device measures these three biomarkers on a single cassette.

With a single sample, in less than 30 minutes and without specialized infrastructure, the doctor obtains the patient's complete metabolic profile and makes preventive decisions in the same consultation.

<30 min

Faster. More accessible. Just as accurate.

$246 MXN

per test (3 biomarkers)

56%+

savings vs. laboratory

2 months

payback for the clinic

results in the clinic

Frontier science + business execution.

Dr. Alejandro Cantón — CEO / EIR

Medical Doctor (MD) with 5 years in strategic management and GTM. Responsible for fundraising, marketing and institutional relations.

Dr. Katerina Kourentzi — CTO

20 years in LFA, design-for-manufacturing and regulatory documentation. Technical supervision of manufacturing and suppliers.

Dr. Mirna González — Lead Inventor

PhD in Biochemistry and Biotechnology · Tec de Monterrey. Developed and validated the LFA-europium platform.

Dr. Richard Willson — Scientific Advisor

University of Houston. LFA Specialist with experience in spin-offs with FDA clearance and international technology transfer.

Technology developed in:

Do you want to bring advanced metabolic diagnostics to your clinic?

We are currently in clinical pilot trials. If you are a physician, clinic administrator, distributor, or investor, please contact us.

Your information is protected in accordance with the Federal Law on the Protection of Personal Data Held by Private Parties.

MetriSense · Point-of-care metabolic diagnostics · Backed by Fill The Blank Innovation and Tecnológico de Monterrey

Product undergoing COFEPRIS Class II registration. Not available for commercial sale until approval is granted.